Guzmán-Esquivel José, Martínez-Contreras Alicia, Ramírez-Flores Mario, Jiménez Ceja Lilia M, Delgado-Enciso Ivan, Martínez-Garza Sandra, Baltazar Rodríguez Luz M
Urology Service, Family Medicine, Zone General Hospital No. 1, Colima, Colima, Mexico.
Int Urol Nephrol. 2009;41(2):335-40. doi: 10.1007/s11255-008-9428-6. Epub 2008 Jul 22.
To determine whether the presence of human papillomavirus (HPV) in men is a risk factor in the development of intraepithelial cervical neoplasia in their sexual partners and to corroborate HPV frequency and type.
A case-control study was carried out in the city of Colima, Mexico, from October 2004 to September 2005. It included the male sexual partners of females presenting with intraepitheleal neoplasia and with negative cervical uterine cytology. The study was approved by the local ethics committee, and participants signed a letter of informed consent. Samples were taken from the penis with a cytobrush and were analyzed by polymerase chain reaction (PCR) with type-specific HPV consensus primers. Statistical analysis was carried out using averages, percentages, and chi-square test for association.
Twenty-one patients and 40 controls were analyzed. Eight were excluded due to DNA degradation. Chi-square test was utilized to find association between risk factor (HPV in men) in men whose sexual partners were women with premalignant lesions and normal Papanicolaou test. There was no statistical significance; OR was 2.5, CI was 0.38-16.41, and P = 0.37 (Fisher's exact test). There was no significant difference between the two study groups. Four HPV-positive cases (19%) were obtained from the case group, and two HPV-positive cases (6%) were obtained from the control group. The six positive samples had low-grade virus. There was no association between HPV in men and the cervical intraepitheleal neoplasia of their sexual partners.
In the present study, HPV in men was not found to be a risk factor in the development of cervical uterine lesions. The viruses that were found were low risk. The sample size employed was not large enough to be able to determine any differences between both study groups.
确定男性感染人乳头瘤病毒(HPV)是否为其性伴侣发生宫颈上皮内瘤变的危险因素,并核实HPV的感染频率及类型。
2004年10月至2005年9月在墨西哥科利马市开展了一项病例对照研究。研究对象包括患有上皮内瘤变且宫颈细胞学检查呈阴性的女性的男性性伴侣。该研究经当地伦理委员会批准,参与者签署了知情同意书。用细胞刷从阴茎取样,采用型特异性HPV通用引物通过聚合酶链反应(PCR)进行分析。采用均值、百分比及卡方检验进行关联分析。
对21例患者和40例对照进行了分析。8例因DNA降解被排除。采用卡方检验来寻找性伴侣患有癌前病变且巴氏试验正常的男性的危险因素(男性感染HPV)之间的关联。无统计学意义;比值比为2.5,可信区间为0.38 - 16.41,P = 0.37(Fisher精确检验)。两个研究组之间无显著差异。病例组有4例HPV阳性(19%),对照组有2例HPV阳性(6%)。6份阳性样本均为低危型病毒。男性感染HPV与其性伴侣的宫颈上皮内瘤变之间无关联。
在本研究中,未发现男性感染HPV是宫颈病变发生的危险因素。所发现的病毒为低危型。所采用的样本量不够大,无法确定两个研究组之间的任何差异。